WuXi Biologics (Cayman) I... (WXIBF)

PNK: WXIBF · Real-Time Price · USD

3.00

0.00 (0.00%)

At close: Apr 29, 2025, 3:47 PM

WuXi Biologics (Cayman) Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	9.67B	6.4B	9B	7.1B	6.21B	4.08B	503.88M	169.1M
Short-Term Investments	1.57B	2.32B	2.12B	1.38B	543M	n/a	1.56B	n/a
Long-Term Investments	2.93B	390.11M	79.62M	-311.32M	-90.84M	192.28M	n/a	n/a
Other Long-Term Assets	461.97M	2.49B	2.32B	1.54B	587.57M	28.87M	28.51M	n/a
Receivables	6.25B	5.16B	3.27B	2.37B	1.38B	798.88M	314.3M	293.87M
Inventory	1.77B	2.28B	1.69B	1.08B	399.39M	227.19M	135.55M	78.99M
Other Current Assets	1.83B	2.32B	3.44B	2.27B	1.15B	634.72M	321.19M	165.2M
Total Current Assets	21.2B	18.47B	19.53B	14.2B	9.67B	5.75B	3.03B	829.86M
Property-Plant & Equipment	29.94B	25.92B	19.76B	12.87B	6.8B	2.9B	1.78B	1.15B
Goodwill & Intangibles	2.04B	2.08B	2.13B	577.26M	601.25M	500.44M	n/a	n/a
Total Long-Term Assets	35.38B	31.09B	24.5B	14.76B	7.93B	3.65B	1.82B	1.16B
Total Assets	56.58B	49.56B	44.03B	28.96B	17.6B	9.39B	4.85B	1.98B
Account Payables	833.27M	794.39M	617.78M	646M	185.81M	220.98M	137.29M	105.03M
Deferred Revenue	430.48M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	576.33M	1.32B	2.12B	767.13M	506.11M	n/a	n/a	222.42M
Other Current Liabilities	4.84B	6.06B	4.56B	2.49B	1.89B	952.34M	572.15M	403.25M
Total Current Liabilities	7.64B	9.32B	8.26B	4.5B	2.87B	1.32B	798.07M	800.83M
Long-Term Debt	1.57B	1.46B	640.51M	1.84B	1.4B	n/a	n/a	866M
Other Long-Term Liabilities	1.09B	n/a	n/a	1.06B	n/a	80.17M	n/a	n/a
Total Long-Term Liabilities	4.92B	4.03B	3.07B	3.57B	1.83B	80.17M	26.53M	913.7M
Total Liabilities	12.56B	13.35B	11.33B	8.06B	4.71B	1.4B	824.6M	1.71B
Total Debt	4.56B	4.42B	4.3B	3.33B	2.19B	n/a	n/a	1.13B
Common Stock	235K	233K	235K	225K	214K	202K	192K	158K
Retained Earnings	14.98B	11.58B	7.16B	3.77B	1.88B	962.23M	394.24M	165.53M
Comprehensive Income	1.78B	1.37B	593.13M	845.18M	443.86M	-556.77M	-349.24M	-227.17M
Shareholders Equity	40.33B	35.05B	32.28B	20.56B	12.78B	7.99B	4.02B	270.47M
Total Investments	2.93B	2.71B	2.2B	1.07B	452.16M	192.28M	1.56B	n/a